US2015259731A1PendingUtilityA1
Design, synthesis and use of synthetic nucleotides comprising charge mass tags
Est. expirySep 3, 2028(~2.1 yrs left)· nominal 20-yr term from priority
Inventors:Jonathan O'Halloran
C12Q 1/6825C12Q 1/6816C07H 19/20C07H 19/04
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Embodiments of the present disclosure relate generally to reporter compositions which are synthetic nucleotides that comprise nucleotides with a high charge mass moiety attached thereto via a linker molecule. The linker molecules can vary in length in part to enable the high charge mass moiety to extend out from a DNA polymerase complex so that polymerization may not be influenced.
Claims
exact text as granted — not AI-modified1 . A reporter composition, comprising:
a nucleotide or its derivative; a linker molecule, wherein the linker molecule is attached to the nucleotide or its derivative and a high charge mass moiety; and a high charge mass moiety, wherein the high charge mass moiety comprises a charge mass that is sufficient to change a property of a sensitive detection nanostructure operably coupled to the reporter composition.
2 . The reporter composition of claim 1 , wherein the nucleotide or its derivative is selected from the group consisting of a deoxyribonucleotide, a ribonucleotide, a peptide nucleotide, a morpholino, a locked nucleotide, a glycol nucleotide, a threose nucleotide, any synthetic nucleotides, any isoforms thereof, and any derivatives thereof.
3 . The reporter composition of claim 1 , wherein the linker molecule comprises a molecule of the following general formula:
H 2 N-L-NH 2
wherein L comprises a linear or branched chain comprising an alkyl group, an oxy alkyl group, or the combination thereof.
4 . The reporter composition of claim 3 , wherein L comprises a linear chain comprising an alkyl group, an oxy alkyl group, or the combination thereof.
5 . The reporter composition of claim 4 , wherein a number of the alkyl group, the oxy alkyl group, or the combination thereof in the linear chain is 1 to 100.
6 . The reporter composition of claim 5 , wherein the number of the alkyl group, the oxy alkyl group, or the combination thereof in the linear chain is 1 to 75.
7 . The reporter composition of claim 5 , wherein the number of the alkyl group, the oxy alkyl group, or the combination thereof in the linear chain is 1 to 50.
8 . The reporter composition of claim 5 , wherein the number of the alkyl group, the oxy alkyl group, or the combination thereof in the linear chain is 1 to 25.
9 . The reporter composition of claim 5 , a number of the alkyl group, the oxy alkyl group, or the combination thereof in the linear chain is 1 to 1000.
10 . The reporter composition of claim 5 , a number of the alkyl group, the oxy alkyl group, or the combination thereof in the linear chain is more than 1000.
11 . The reporter composition of claim 1 , wherein the linker molecule is configured not to affect nucleotide polymerization by a polymerase.
12 . The reporter composition of claim 1 , wherein a net charge mass of the high charge mass moiety is positive or negative.
13 . The reporter composition of claim 1 , wherein a net charge mass of the high charge mass moiety is variable depending on pH.
14 . The reporter composition of claim 1 , wherein the high charge mass moiety comprises an aromatic and/or aliphatic skeleton, wherein said skeleton comprises one or more of a tertiary amino group, an alcohol hydroxyl group, a phenolic hydroxy group, and any combinations thereof.
15 . The reporter composition of claim 1 , wherein the high charge mass moiety comprises one or more of the following groups, and derivatives and combinations thereof:
16 . The reporter composition of claim 15 , wherein a number of the groups, any derivatives thereof, and any combinations thereof in the high charge mass moiety is 1 to 10.
17 . The reporter composition of claim 15 , wherein a number of the groups, any derivatives thereof, and any combinations thereof in the high charge mass moiety is 11 to 50.
18 . The reporter composition of claim 15 , wherein a number of the groups, any derivatives thereof, and any combinations thereof in the high charge mass moiety is 51 to 100.
19 . The reporter composition of claim 15 , wherein a number of the groups, any derivatives thereof, and any combinations thereof in the high charge mass moiety is more than 100.
20 . The reporter composition of claim 1 , wherein the high charge mass moiety is configured not to affect nucleotide polymerization by a polymerase.
21 - 28 . (canceled)Join the waitlist — get patent alerts
Track US2015259731A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.